Skip to content

Pelvic Muscle Training and Electrostimulation to Treat Weak Pelvic Floor

Efficacy of PFMT and sEMG-triggered Electrostimulation in Treating the Very Weak Pelvic Floor: a Randomized Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06419517
Enrollment
50
Registered
2024-05-17
Start date
2024-05-17
Completion date
2025-12-31
Last updated
2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electricity; Effects, Incontinence Stress, Muscle Weakness Condition, Pelvic Floor Muscle Weakness

Keywords

Pelvic Floor Muscle Weakness, Electrical Stimulation, Pelvic Floor Muscle Training

Brief summary

This research will determine 1) whether the very weak pelvic floor can be improved with surface electromyography (s-EMG)-triggered electrostimulation added to pelvic floor muscle training and 2) whether sEMG-triggered electrostimulation added to pelvic floor muscle training can reduce leakage in Stress Urinary Incontinence (SUI)

Detailed description

Among women with pelvic floor dysfunction, it has long been known that PFM training is the first-line therapy for stress incontinence. One of the difficulties that clinicians often find upon examination is that many women present a very weak pelvic floor and are unable to contract their PFM. There is overwhelming evidence to show that conservative treatment in the form of pelvic muscle exercises (and to a lesser degree, electrotherapy, and vaginal weight therapy) is effective in the treatment of stress urinary incontinence. To date, there is some evidence to support the use of electrical stimulation for stress urinary incontinence in women, but we are still very uncertain about the full potential of this treatment because of the low quality of the existing evidence.

Interventions

DEVICEEMG-triggered ES

The ES treatment protocol consisted of daily endovaginal electrostimulation sessions for four weeks. We used a portable unit EVOSTIM ®, which allowed us to use different frequencies and length of impulse and a probe Perisphera ® The average current intensity was adjusted according to the sensation of discomfort in each patient.

OTHERPelvic Floor Muscle Training

Standardization of the supervised PFMT To achieve standardization of supervised PFMT treatments, a written protocol for the physiotherapeutic examinations and PFMT program will be provided to the physiotherapists (or nurse or midwife) delivering the treatments (See Additional file).

Sponsors

Azienda Unita Sanitaria Locale di Piacenza
Lead SponsorOTHER
BEACMED s.r.l.
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double (participants, principal investigator). To improve the effect of blindness, participants were informed that the trial intended to compare the effects of two Electrical Stimulation (ES) methods for Stress Urinary Incontinence (SUI)

Intervention model description

Multicentric Prospective Clinical Trial with two parallel arms

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* • Adult women (18 years old - 50 years old), with a Modified Oxford Score, determined by digital palpation, of 0 - 1, complaining leakage episode occurring more than once a week. * Between six and eighteen months after childbirth * Willing and able to be compliant with pelvic floor muscle exercise intervention (standard of care) for 12 weeks and to log compliance * Willing and able to undergo an extensive physical function evaluation

Exclusion criteria

* • pregnancy * severe neurological disease (Multiple Sclerosis, Parkinson's disease, spinal cord injury, major stroke or neuromuscular junction diseases) * previous operation for cancer or radiotherapy in the lower abdomen * Prior surgical intervention for urinary incontinence within the past 12 months * Hysterectomy within 12 months * voiding dysfunction * pelvic pain * severe prolapse (≥ grade 3) * recurrent urinary tract infection * pelvic or disseminated malignancies * women who were virgo intacta * women who declined vaginal examinations for any reasons * before four months of pregnancy * Having significant cognitive impairment or dementia * Unsafe to exercise (severe cardiopulmonary disease) * Unable/unwilling to provide informed consent * Patient has on physical examination, neurological and/or vaginal examination results which, in the opinion of the investigator, should exclude the subject.

Design outcomes

Primary

MeasureTime frameDescription
Pelvic Floor Muscles (PFM) StrengthBaseline, four weeks, 6 and 12 months follow-upPFM strength by digital palpation done in the lithotomy position

Secondary

MeasureTime frameDescription
Frequency/volume chartBaseline, four weeks, 6 and 12 months follow-upThe change incontinence frequency (n.of episodes) deducted by frequency/volume chart
International Consultation on Incontinence Questionnaire-Short Form(ICIQ-SF)Baseline, four weeks, 6 and 12 months follow-upChange of "International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF" scores, which varie from 0 (no impact of incontinence) to 19 (worst impact of incontinence in everyday life)

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATORGianfranco Lamberti, MD

Azienda USL Piacenza

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026